产品信息
| 产品号 | 商品名 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 参比药物(RLD) | 生物等效参考标准(RS) | 治疗等效代码 | 该申请号批准日期 | 该产品号批准日期 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|
| 001 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | TABLET;SUBLINGUAL | EQ 1.4MG BASE;EQ 0.36MG BASE | No | No | None | 2023/08/11 | -- | None (Tentative Approval) |
| 002 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | TABLET;SUBLINGUAL | EQ 5.7MG BASE;EQ 1.4MG BASE | No | No | None | -- | None (Tentative Approval) | |
| 003 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | TABLET;SUBLINGUAL | EQ 8.6MG BASE;EQ 2.1MG BASE | No | No | None | -- | None (Tentative Approval) | |
| 004 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | TABLET;SUBLINGUAL | EQ 11.4MG BASE;EQ 2.9MG BASE | No | No | None | -- | None (Tentative Approval) | |
| 005 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | TABLET;SUBLINGUAL | EQ 2.9MG BASE;EQ 0.71MG BASE | No | No | None | -- | None (Tentative Approval) | |
| 006 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | TABLET;SUBLINGUAL | EQ 0.7MG BASE;EQ 0.18MG BASE | No | No | None | -- | None (Tentative Approval) |